Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Stanford University
Wake Forest University Health Sciences
AstraZeneca
Fondazione del Piemonte per l'Oncologia
Fred Hutchinson Cancer Center
Mayo Clinic
BioNTech SE
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Ohio State University
STORM Therapeutics LTD
Pfizer
M.D. Anderson Cancer Center
Neonc Technologies, Inc.
ViroMissile, Inc.
Hummingbird Bioscience
University of Cincinnati
Bristol-Myers Squibb
AstraZeneca
Washington University School of Medicine
University of Florida
Radiopharm Theranostics, Ltd
Arvinas Inc.
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Essen Biotech
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
Shanghai Henlius Biotech
Wake Forest University Health Sciences
DualityBio Inc.
MacroGenics
Alliance for Clinical Trials in Oncology
Novartis
Pfizer
Daiichi Sankyo
Beijing Tide Pharmaceutical Co., Ltd
University of Nebraska
NRG Oncology
Goethe University
Elephas
Innate Pharma
City of Hope Medical Center
Elephas
Mayo Clinic
Mayo Clinic
Linnaeus Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center